Date |
Symbol |
Description |
Type |
Disease |
Designation |
Success Rating |
10/22/2016
|
OPK |
|
PDUFA |
Endocrine |
None |
|
Q1 2017
|
PBYI |
|
Phase 3 Results |
Oncology |
None |
|
07/19/2016
|
VRX |
|
PDUFA |
Other |
None |
|
H2 2016
|
MDGN |
|
Phase 1/2 Results |
Other |
None |
|
H2 2016
|
MDGN |
|
Phase 2/3 Results |
Other |
None |
|
Q4 2016
|
PTN |
|
Phase 3 Results |
Other |
None |
|
Q4 2016
|
PTN |
|
Phase 3 Results |
Other |
None |
|
12/28/2016
|
CEMP |
|
PDUFA |
Other |
Fast Track |
|
Q4 2016
|
PBYI |
|
Phase 2 Results |
Oncology |
None |
|
Q3 2017
|
PBYI |
|
PDUFA |
Oncology |
None |
|